Draganfly’s Health Safety Program Selected by The University of Alabama at Birmingham
December 09, 2021 07:45 ET | Draganfly Inc
Draganfly’s Varigard pathogen and surface sanitizer spray will be implemented at the University of Alabama at Birmingham ahead of Fall 2021 Commencement ceremonies Los Angeles, CA., Dec. 09, 2021 ...
BrainsWay 2021 logo.jpg
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
December 09, 2021 07:30 ET | BrainsWay
Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol Consumption and Craving for Adults with Alcohol Use Disorder Study Findings to be Featured...
Vivos logo.jpg
Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep Disorder, Snoring and Sleep Apnea Appliances to Canadian Dentists
December 09, 2021 07:30 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Minim President Named A “Female Executive of the Year” and “Most Innovative Woman” By Stevie Awards for Women in Business Worldwide
December 09, 2021 07:30 ET | Minim
Nicole Zheng will join female leaders from around the world on a virtual stage to accept two Silver Stevie® Awards for excellence in Consumer Products and Technology MANCHESTER, NH, Dec. 09, 2021 ...
SuRo Capital Corp. Commences Offering of Notes
December 09, 2021 07:30 ET | SuRo Capital Corp.
SAN FRANCISCO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq:SSSS) today announced that it has commenced an underwritten offering of unsecured notes...
Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer
December 09, 2021 07:30 ET | Purple Biotech Ltd.
REHOVOT, Israel, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Announces Receipt of Breakthrough Therapy Designation from FDA for Aficamten
December 09, 2021 07:30 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
GENE logo.png
Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO
December 09, 2021 07:30 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
December 09, 2021 07:28 ET | Ocugen
Gene therapy candidate has potential to address a large number of retinitis pigmentosa and Leber congenital amaurosis gene mutations with a single productTrial to start in Q1 2022 will enroll patients...
uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B
December 09, 2021 07:05 ET | uniQure Inc.
~ Largest gene therapy study in hemophilia B achieved primary endpoint of non-inferiority in annualized bleeding rate after stable Factor IX (FIX) expression, assessed at 18 months following a single...